3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma, Squamous Cell
3
Rectal Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Adenocarcinoma Of Esophagus
2
Tonsillar Neoplasms
1
Resectable Esophageal Cancer
1
Pharyngeal Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Muscle Invasive Bladder Cancer
1
Melanoma
1
Lung Neoplasms
1
Limited Stage Small Cell Lung Cancer
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Adenosquamous
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Trastuzumab
243
Paclitaxel
193
Cyclophosphamide
158
Docetaxel
134
Letrozole
113
Capecitabine
113
Fulvestrant
106
Doxorubicin
103
Bevacizumab
87
Carboplatin
81
exemestane
80
Anastrozole
79
Lapatinib
70
Tamoxifen
69
Albumin-Bound Paclitaxel
57
palbociclib
54
pertuzumab
53
Taxes
51
Gemcitabine
50
Radiotherapy
46
eribulin
43
pembrolizumab
41
Everolimus
41
Ado-Trastuzumab Emtansine
41
Vinorelbine
38
130-nm albumin-bound paclitaxel
35
ixabepilone
32
Epirubicin
28
pegfilgrastim
25
liposomal doxorubicin
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms
×
Chemoradiotherapy
×
Clear all
No trials found.